RxDoctor Payments DataLook up a doctor →

Kenneth Pugar, DO

Neurology · Centerville, OHNPI 1528060399

Payments from drug & device makers

$1,907,073in general payments, 2019–2025

Across 1,813 payments — averaging $1051.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$1.1M
  • EMD Serono, Inc.$218K
  • Novartis$212K
  • Biogen$200K
  • Eisai Inc.$38K
  • Lilly USA, LLC$31K
  • plus $125K from 54 others
$14,525in research payments, 2019–2025

Across 6 payments — averaging $2420.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Acadia Pharmaceuticals Inc$15K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi179$1,082,547
EMD Serono, Inc.235$218,259
Novartis92$212,213
Biogen193$200,386
Eisai Inc.62$37,849
Lilly USA, LLC92$31,010
Avanir Pharmaceuticals, Inc.34$25,665
MDD US Operations, LLC219$24,667
Acadia Pharmaceuticals Inc41$19,729
Eli Lilly3$16,236
Genentech, Inc.7$14,270
AbbVie(2 entities)144$9,360
Genentech USA, Inc.25$5,036
AstraZeneca(2 entities)41$1,173
Amgen(2 entities)46$1,155
Teva Pharmaceuticals USA, Inc.56$984
UCB, Inc.39$755
Neurocrine Biosciences, Inc.33$491
Pfizer28$469
Biohaven Pharmaceutical Holding Company Ltd.20$459
Johnson & Johnson19$442
SK Life Science, Inc.21$375
Biohaven Pharmaceuticals, Inc.18$359
Amneal Pharmaceuticals LLC17$330
Acorda Therapeutics, Inc20$323
Sunovion Pharmaceuticals Inc.16$268
Lundbeck LLC9$166
TG Therapeutics, Inc.5$156
E.r. Squibb & Sons, L.L.C.3$148
Argenx US, Inc.6$144
Axsome Therapeutics, Inc.7$137
Abbott1$129
Supernus Pharmaceuticals, Inc.6$98
Jazz Pharmaceuticals Inc.5$96
CSL Behring7$96
Kyowa Kirin, Inc.4$94
Amylyx Pharmaceuticals, Inc.5$84
Ipsen Biopharmaceuticals, Inc5$75
Grifols USA, LLC4$73
Otsuka America Pharmaceutical, Inc.3$73
Adamas Pharmaceuticals, Inc.5$71
Takeda Pharmaceuticals U.S.A., Inc.3$60
Merz Pharmaceuticals, LLC3$57
Bristol Myers Squibb3$51
Zyla Life Sciences, Inc.3$40
Vanda Pharmaceuticals Inc.1$39
Octapharma USA, Inc.2$39
Alnylam Pharmaceuticals Inc.2$34
Tanabe Pharma America, Inc.2$33
Harmony Biosciences LLC2$32
Catalyst Pharmaceuticals, Inc.1$27
Boston Scientific1$26
Vertical Pharmaceuticals, LLC2$24
Portola Pharmaceuticals, LLC2$24
Philips North America LLC1$22
Medtronic1$21
Neurelis, Inc.1$19
Cala Health, Inc.1$17
Merz North America, Inc.1$16
Corium, LLC1$13

How this compares

$1,907,073 in reported general payments places this provider in the 95th percentile of 702 neurology providers in Ohio.

See all neurology providers in Ohio →

Medicare billing

Part B allowed, 2024
$194,728
Medicare patients
275
Services billed
3,059

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Centerville

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →